Fomento Economico Mexicano (FMX)vsNovo Nordisk A/S (NVO)
FMX
Fomento Economico Mexicano
$108.51
+2.56%
CONSUMER DEFENSIVE · Cap: $36.56B
NVO
Novo Nordisk A/S
$36.33
-1.52%
HEALTHCARE · Cap: $165.02B
Smart Verdict
WallStSmart Research — data-driven comparison
Fomento Economico Mexicano generates 172% more annual revenue ($840.95B vs $309.06B). NVO leads profitability with a 33.1% profit margin vs 2.3%. NVO appears more attractively valued with a PEG of 4.88. FMX earns a higher WallStSmart Score of 59/100 (C).
FMX
Buy59
out of 100
Grade: C
NVO
Buy55
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+15.9%
Fair Value
$134.78
Current Price
$108.51
$26.27 discount
Margin of Safety
-59.4%
Fair Value
$24.21
Current Price
$36.33
$12.12 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 63.8% YoY
Generating 9.5B in free cash flow
Attractively priced relative to earnings
Every $100 of equity generates 61 in profit
Keeps 33 of every $100 in revenue as profit
Strong operational efficiency at 44.5%
Large-cap with strong market position
Areas to Watch
Premium valuation, high expectations priced in
2.3% margin — thin
Weak financial health signals
Expensive relative to growth rate
Weak financial health signals
Expensive relative to growth rate
Revenue declined 7.6%
Earnings declined 4.7%
Comparative Analysis Report
WallStSmart ResearchBull Case : FMX
The strongest argument for FMX centers on EPS Growth, Free Cash Flow.
Bull Case : NVO
The strongest argument for NVO centers on P/E Ratio, Return on Equity, Profit Margin. Profitability is solid with margins at 33.1% and operating margin at 44.5%.
Bear Case : FMX
The primary concerns for FMX are P/E Ratio, Profit Margin, Piotroski F-Score. Thin 2.3% margins leave little buffer for downturns.
Bear Case : NVO
The primary concerns for NVO are Piotroski F-Score, PEG Ratio, Revenue Growth.
Key Dynamics to Monitor
FMX profiles as a value stock while NVO is a declining play — different risk/reward profiles.
NVO carries more volatility with a beta of 0.27 — expect wider price swings.
FMX is growing revenue faster at 5.4% — sustainability is the question.
FMX generates stronger free cash flow (9.5B), providing more financial flexibility.
Bottom Line
FMX scores higher overall (59/100 vs 55/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Fomento Economico Mexicano
CONSUMER DEFENSIVE · BEVERAGES - BREWERS · USA
Fomento Econmico Mexicano, SAB de CV, is a bottler of Coca-Cola brand beverages. The company is headquartered in Monterrey, Mexico.
Novo Nordisk A/S
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally. The company is headquartered in Bagsvaerd, Denmark.
Compare with Other BEVERAGES - BREWERS Stocks
Want to dig deeper into these stocks?